Home
Capsida Biotherapeutics

Capsida Biotherapeutics Market Share Analysis for March 2026

Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening disorders.

Industry: N/A

Domaincapsida.com

Year Founded2019

Employees51 - 200

Annual Revenue$2M - $5M

Capsida Biotherapeutics

Capsida Biotherapeutics (including company regionals)

capsida.com

See more website traffic and engagement information

Capsida Biotherapeutics Revenue up to March 2026 is 2M - 5M

revenue generated by Capsida Biotherapeutics top domains

Capsida Biotherapeutics top domains revenue over 3 years

Revenue for Capsida Biotherapeutics top domains

capsida.com2M - 5M

See more with Sales Intelligence

Total visits to Capsida Biotherapeutics's top domains

Understand Capsida Biotherapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

capsida.com4.1K

See more with Sales Intelligence

Avg. visit duration in Capsida Biotherapeutics's top domains

Analyze Capsida Biotherapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

capsida.com00:00:29

See more with Sales Intelligence

Avg. pageviews on Capsida Biotherapeutics's top domains

See how Capsida Biotherapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

capsida.com2.08

See more with Sales Intelligence

Capsida Biotherapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Capsida Biotherapeutics

These are the website technologies, by industry, used by Capsida Biotherapeutics top domains

Email Services (3)

G Suite

Widget (3)

Twemoji

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

More Technologies

7

See all

News & Signals from Capsida Biotherapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAnastasiou left Capsida Biotherapeutics Inc. as Chief Executive Officer on Apr 1st '26.Most recently, Mr. Anastasiou served as Chief Executive Officer of Capsida Biotherapeutics and previously held multiple leadership roles at Lundbeck, including President of U.S. and Canadian operations and U.S. Chief Commercial Officer for its psychiatry and neurology franchises.

NewsCapsida Biotherapeutics Inc. attended event ASGCT Annual Meeting on May 14th '25.Capsida will deliver these data in an oral presentation today at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 13-17, 2025, in New Orleans and virtually.

NewsCapsida Biotherapeutics Inc. attends event 2025 MDA Clinical & Scientific Conference.Research presented by Capsida at the 2025 MDA Clinical & Scientific Conference showed that a single intravenous administration of CAP-004 successfully delivered its genetic payload to critical disease-relevant tissues, including the heart, sensory nerves, and the central nervous system (CNS), which encompasses the brain and spinal cord.